Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Oct;28(10):954-957.
doi: 10.1111/resp.14575. Epub 2023 Aug 21.

A randomized trial of pamrevlumab in patients with COVID-19 pneumonia

Giacomo Sgalla  1 , Paolo Maria Leone  1 , Gina Gualano  2 , Jacopo Simonetti  1 , Alessia Comes  1 , Diana Verdirosi  1 , Francesco Di Gennaro  2 , Anna Rita Larici  3 , Stefania Ianniello  4 , Giuseppe Cicchetti  3 , Nicoletta Fusco  4 , Marcello Pani  5 , Fabrizio Palmieri  2 , Luca Richeldi  1
Affiliations
Free article
Randomized Controlled Trial

A randomized trial of pamrevlumab in patients with COVID-19 pneumonia

Giacomo Sgalla et al. Respirology. 2023 Oct.
Free article
No abstract available

Keywords: COVID-19; interstitial lung disease; lung fibrosis; pulmonary fibrosis.

PubMed Disclaimer

References

REFERENCES

    1. Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20:425-434.
    1. Polak SB, van Gool IC, Cohen D, von der Thusen JH, van Paassen J. A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression. Mod Pathol. 2020;33:2128-2138.
    1. Huang W, Wu Q, Chen Z, Xiong Z, Wang K, Tian J, et al. The potential indicators for pulmonary fibrosis in survivors of severe COVID-19. J Infect. 2021;82:e5-e7.
    1. Safont B, Tarraso J, Rodriguez-Borja E, Fernandez-Fabrellas E, Sancho-Chust JN, Molina V, et al. Lung function, radiological findings and biomarkers of fibrogenesis in a cohort of COVID-19 patients six months after hospital discharge. Arch Bronconeumol. 2022;58:142-149.
    1. Lombardi F, Calabrese A, Iovene B, Pierandrei C, Lerede M, Varone F, et al. Residual respiratory impairment after COVID-19 pneumonia. BMC Pulm Med. 2021;21:241.

Publication types

Substances

Associated data